Related Experiment Video
Updated: Jul 10, 2026

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
Published on: December 21, 2016
Altered degradation of circulating nucleic acids and oligonucleotides in diabetic patients
G Kocic1, G Bjelakovic, Lj Saranac
1Institute of Biochemistry, Medical Faculty University of Nis, Serbia. kocicrg@yahoo.co.uk
Abstract:
Foreign, infection-associated or endogenously generated circulating nucleotide motifs may represent the critical determinants for the activation of the Toll-like receptors (TLRs), leading to immune stimulation and cytokine secretion. The importance of circulating nucleases is to destroy nucleic acids and oligonucleotides in the blood stream and during cell entry. Patients with juvenile insulin-dependent diabetes, adult patients with insulin-dependent diabetes and adult patients with type 2 diabetes were allocated to the study, together with the age-matched control subjects. Plasma RNase and nuclease activity were examined, in relation to different substrates-TLRs response modifiers, and circulating RNA and oligonucleotides were isolated. The fall in enzyme activity in plasma was obtained for rRNA, poly(C), poly(U), poly(I:C), poly(A:U) and CpG, especially in juvenile diabetics. In order to test the non-enzymatic glycation, commercial RNase (E.C.3.1.27.5) and control plasma samples were incubated with increasing glucose concentrations (5, 10, 20 and 50 mmol/l). The fall of enzyme activity was expressed more significantly in control plasma samples than for the commercial enzyme. Total amount of purified plasma RNA and oligonucleotides was significantly higher in diabetic patients, especially in juvenile diabetics. The increase in the concentration of nucleotides corresponded to the peak absorbance at 270 nm, similar to polyC. The electrophoretic bands shared similar characteristics between controls and each type of diabetic patients, except that the bands were more expressed in diabetic patients. Decreased RNase activity and related increase of circulating oligonucleotides may favor the increase of nucleic acid "danger motifs", leading to TLRs activation.
Insights
Reduced RNase activity in diabetic patients, particularly juvenile diabetics, leads to increased circulating oligonucleotides. This may promote Toll-like receptor (TLR) activation and immune responses.
Area of Science:
- Immunology
- Biochemistry
- Endocrinology
Background:
- Circulating nucleotide motifs can activate Toll-like receptors (TLRs), initiating immune responses.
- Nucleases in blood are crucial for degrading nucleic acids and oligonucleotides.
- Diabetes mellitus is associated with immune dysregulation.
Purpose of the Study:
- To investigate plasma RNase and nuclease activity in diabetic patients.
- To examine the levels of circulating RNA and oligonucleotides in diabetes.
- To explore the link between reduced nuclease activity, increased nucleic acids, and TLR activation in diabetes.
Main Methods:
- Assessed plasma RNase and nuclease activity using various substrates (rRNA, poly(C), poly(U), poly(I:C), poly(A:U), CpG).
- Quantified circulating RNA and oligonucleotides in patients with juvenile insulin-dependent diabetes, adult insulin-dependent diabetes, type 2 diabetes, and age-matched controls.
- Investigated the effect of glucose on commercial RNase and control plasma enzyme activity to assess non-enzymatic glycation.
Main Results:
- Plasma RNase and nuclease activity were significantly lower in diabetic patients, especially juvenile diabetics.
- Total amounts of circulating RNA and oligonucleotides were elevated in diabetic patients compared to controls.
- Incubation with glucose demonstrated a more significant fall in enzyme activity in control plasma than in commercial RNase, suggesting glycation impacts.
Conclusions:
- Decreased plasma RNase activity in diabetes contributes to higher levels of circulating oligonucleotides.
- Elevated nucleic acids may act as 'danger motifs,' potentially activating Toll-like receptors (TLRs).
- This mechanism could link diabetes to altered immune stimulation and cytokine secretion.
Related Concept Videos
Diabetic Neuropathy
Diabetic Nephropathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology
Hyperglycemia
Type I Diabetes III: Clinical Manifestations
